Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique

Journal of Medical Virology

Volumn 82, Issue 9, 2010, Pages 1576-1581

  Caterino De Araujo, Adele ^a,b   Magri, Mariana Cavalheiro ^a,b   Manuel, Rolanda Carmen Rafael ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

Author keywords

Cancer; HHV 8; HIV; Immunofluorescence assay; Immunology; Risk prediction

Indexed keywords

LATENT ANTIGEN; LYTIC ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOZAMBIQUE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOZAMBIQUE; NUCLEAR PROTEINS; REPRESSOR PROTEINS; SARCOMA, KAPOSI; VIRAL PROTEINS;

HUMAN HERPESVIRUS 8;

EID: 77956596971     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21854     Document Type: Article

References (33)

1. Aoki Y, Tosato G. 2004. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 104:810-814. (Pubitemid 38970578)
2. Aresté C, Blackbourn DJ. 2009. Modulation of the immune system by Kapos's sacoma-associated herpesvirus. Trends Microbiol 17:119-129.
3. Avelleira JCR, Lupi O, Caterino-de-Araujo A, Santos-Fortuna E. 2006. Seroprevalence of HHV-8 infection in the pediatric population of two university hospitals in Rio de Janeiro, Brazil. Intern J Dermatol 45:381-383.
4. Campbell TB, Borok M, White IE, Gudza I, Ndemera B, Taziwa A, Weinberg A, Gwanzura L. 2003. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clin Infect Dis 36:1144-1151. (Pubitemid 36549635)
5. Cassol E, Page T, Mosam A, Friedland G, Jack C, Lalloo U, Kopetka J, Patterson B, Esterhuizen T, Coovadia HM. 2005. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or Human herpesvirus-8. J Infect Dis 191:324-332. (Pubitemid 40139756)
6. Caterino-de-Araujo A. 2007. The fight against Kaposi's sarcoma in AIDS - Lessons from Brazil. S Afr J HIV Med 26:53-54.
7. Caterino-de-Araujo A, Cibella SEL. 2003. Searching for antibodies to HHV-8 in children born to HIV-1 infected mothers from São Paulo, Brazil. Relationship to maternal infection. J Trop Pediatr 49:247-250. (Pubitemid 36949651)
8. Caterino-de-Araujo A, Santos-Fortuna E, Carbone PHL, Cibella SE, Moreira AA. 2003. Human herpesvirus 8 (HHV-8) antibodies among women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma. Braz J Infect Dis 7:395-401.
9. Caterino-de-Araujo A, Magri MC, Santos-Fortuna E, Souza JF, Sens YAS, Pedro J. 2007a. Human herpesvirus 8 infection in hemodialysis patients from São Paulo, Brazil: Preliminary results. Transpl Proc 39:3044-3046. (Pubitemid 350251429)
10. Caterino-de-Araujo A, Santos-Fortuna E, Magri MC, Schuelter-Trevisol F, Silva MV. 2007b. Latent Human Herpesvirus-8 (HHV-8) infection in female commercial sex workers from Imbituba, Santa Catarina, Brazil. Braz J Infect Dis 11:9-11. (Pubitemid 47024088)
11. Caterino-de-Araujo A, Manuel RCR, Del Bianco R, Santos-Fortuna E, Magri MC, Silva JMK, Bastos R. 2009. First survey for detecting the presence of human herpesvirus 8 infection (HHV-8) in Maputo, Mozambique. Braz J Infect Dis 13:200-202.
12. Caterino-de-Araujo A, Manuel RCR, Del Bianco R, Santos-Fortuna E, Magri MC, Silva JMK, Bastos R. 2010. Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: Potential for endemic and epidemic Kaposi's sarcoma. J Med Virol 82:1216-1223.
13. Ceffa S, Buonomo E, Altan AM, Erba F, Germano P, Guidotti G, Liotta G, Magnano San Lio P, Scarcella P, Palombi L, Marazzi MC. 2007. Seroprevalence of HHV-8 in a cohort of HIV-negative and HIV-positive patients in Mozambique. Ann Ig 19:519-523.
14. Cunha AMG, Caterino-de-Araujo A, Costa SCB, Santos-Fortuna E, Boa-Sorte NCA, Gonçalves MS, Costa FF, Galvão-Castro B. 2005. Increasing seroprevalence of Human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86:2433-2437. (Pubitemid 41167590)
15. Dedicoat M, Newton R. 2003. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 88:1-3. (Pubitemid 36241209)
16. Flanigan TP, Campbell T, Harwell J, Kumarasamy N. 2005. The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or Kaposi sarcoma!). J Infect Dis 191:321-323. (Pubitemid 40139755)
17. Harrington W, Sieczkouski L, Sosa C, Chan-a-Sue S, Cai JP, Cabral L, Wood C. 1997. Activation of HHV-8 by HIV-1 tat. Lancet 349:774-775.
18. Hengee UR, Ruzicka T, Tyring SK, Seeber S. 2002. Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part 1: Epidemiology, environmental predispositions, and therapy. Lancet Inf Dis 2:281-292.
19. Jones JL, Hanson DL, Dworkin MS, Jaffe HW. 2000. Incidence and trends in Kaposi's saecoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24:270-274.
20. Leão JC, Caterino-de-Araujo A, Porter SR, Scully C. 2002. Human Herpesvirus 8 (HHV-8) and the etiopathogenesis of Kaposi's sarcoma. Rev Hosp Clin Fac Med Sao Paulo 57:175-186.
21. Magri MC, Canziani MEF, Draibe SA, Santos-Fortuna E, Caterino-de-Araujo A. 2008. Confirming high prevalence of human herpesvirus 8 infection in chronic kidney disease patients from São Paulo, Brazil. NDT Plus 1:93-94.
22. Magri MC, Carbone PHL, Santos-Fortuna E, Caterino-de-Araujo A. 2009. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma. J Med Virol 81:1292-1297.
23. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. 2000. Use of epidemiologically well-defined subjects and existing immunofluorescence assay to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol 38:696-701. (Pubitemid 30082665)
24. Mohanna S, Portillo JA, Carriquiry G, Vidal J, Ferrufino JC, Sanchez J, Bravo F, Gotuzzo E. 2007. Human herpesvirus-8 in Peruvian blood donors: A population with hyperendemic disease? Clin Infect Dis 44:558-561.
25. Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos F, Boshoff C. 2006. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. Br J Can 94:1504-1509.
26. Pérez C, Tous M, Benetucci J, Gómez J. 2006. Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations. J Med Virol 78:806-813.
27. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Buttò S, Lodi G, Di Carlo A, Levy JA, Ensoli B. 1998. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 77:361-365.
28. Schulz TF. 2000. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis. J Antimicrobial Chem 45:15-27.
29. Silva JMK, Magri MC, Jacob F, Santos-Fortuna E, Caterino-de-Araujo A. 2007. Otimização e avaliação do ensaio de imunofluorescência indireta para pesquisa de anticorpos anti-herpesvírus humano 8 (HHV-8) usando sangue colhido em papel de filtro. Rev Inst Adolfo Lutz 6:68-72.
30. Simonart T. 2006. Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma. Cancer Lett 244:1-7.
31. Sissolak G, Mayaud P. 2005. AIDS-related Kaposi's sarcoma: Epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Internal Health 10:981-992.
32. Szajerka T, Jablecki J. 2007. Kaposi's sarcoma revisited. AIDS Rev 9:230-236.
33. Whitby D, Marshall VA, Bagni RK, Miley WJ, MacCloud TG, Hines-Boykin R, Goedert JJ, Conde BA, Nagashima K, Mikovits J, Dittmer DP, Newman DJ. 2006. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Int J Cancer 120:321-328.